Friday, September 26, 2014

New York: Macro Outcome and strong dollar inhibits the stock market, the S & P 500 -0.9% – Dagens Industri

New York: Macro Outcome and strong dollar inhibits the stock market, the S & P 500 -0.9% – Dagens Industri

New York: Macro Outcome and strong dollar inhibits the stock market, S & amp; P 500 -0.9%

                  2014-09-25 16:20
             

 (SIX) New York stock exchanges have started lower on Thursday. Macro data  over orders for durable goods fell more than expected in August, which  together with a strong dollar helps to keep the back  risk sentiment. Regarding individual company name was pushed by Apple  technology hassles and Darden as well as Allergan continued ownership shifts.      The Dow Jones industrial average was recorded at 16:11 on the 0.7 per cent  lower at 17,084. In the broader market fell S & amp; P 500 by 0.9  percent to 1,981, while the Nasdaq Composite fell by 1.2 percent to  4.501.       The interest rate on the ten-year bond climbed 4 basis points lower to 2.53  percent while also trettioårsräntan fell 5 points  to 3.23 percent.       Apple fell 2.5 percent after the company decided to withdraw its  latest version of the iOS operating system 8, after complaints from customers.       Restaurant Dardens Company's management and board is under continued  heavy  pressure from activist investor Starboard Value. Now  Starboard, which bought at the 8.8 percent of the share capital of Darden  wrote an open letter to shareholders in which Dardens man men  them to vote in Starboards total of twelve different candidates to the Board of  Board. Darden shares traded 0.4 percent lower in the afternoon.       Allergan has now responded to drugs colleague Valeant last  attempted to get into a conversation about a possible merger.  Allergan does not mention the specific correspondence that Valeant itself  published on Wednesday, but notes that the company has not changed its  attitude that the company will be able to create more shareholder value  without interference from Valeant. Valeant laid last summer a hostile bid  at Allergan, which was rejected.       In the afternoon, noted Allergan +0.1 percent and +2.6 Valeant  percent.       Boston Scientific is burdened by reporting on a dispute about  royalty payments amounting  to 308 million dollars. The stock has  opened down 1.2 percent.       Statistics outcome of orders for durable goods were received in  prior expectations. August figure showed a decline of 18.2  percent compared with the previous month. Waited was -17.1 percent.       Regarding the weekly change in the number of new job seekers received this  slightly better than expected at 293,000 people. Waited was 300,000.       Before the evening is expected Fed member Dennis Lockhart keep a  speech starting at 19:20 Swedish time.    Johan Eklund, +46 31 350 64 87  mailto: johan.eklund@six-group.se  www.blogg.six.seSIXNews  SIX News 

LikeTweet

No comments:

Post a Comment